1619. Meta-analysis of Randomized Control Trials Evaluating New Beta-Lactamase Combination Antibiotics

BACKGROUND: Ceftolozane/ Tazobactam (C/T), Ceftazidime/ Avibactam (C/A), Meropenem/ Vaborbactam (M/V) and Imipenem/ Relebactam (I/R) are new combination beta-lactam/ beta-lactamase inhibitor antibiotics primarily used to treat multidrug-resistant (MDR) Gram-negative infections. This study synthesize...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Geneva M, Fitzpatrick, Margaret A, Walding, Kyle, Gonzalez, Beverly, Suda, Katie J, Evans, Charlesnika T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776762/
http://dx.doi.org/10.1093/ofid/ofaa439.1799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776762/
http://dx.doi.org/10.1093/ofid/ofaa439.1799

Ejemplares similares